Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin
Ye An Kim (Kim YA), Won Sang Yoo (Yoo WS), Eun Shil Hong (Hong ES), Eu Jeong Ku (Ku EJ), Kyeong Seon Park (Park KS), Soo Lim (Lim S), Young Min Cho (Cho YM), Kyong Soo Park (Park KS), Hak Chul Jang (Jang HC), Sung Hee Choi (Choi SH)
Diabetes Metab J. 2015;39(6):489-497.   Published online 2015 Nov 27     DOI: https://doi.org/10.4093/dmj.2015.39.6.489
Citations to this article as recorded by Crossref logo
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes
Eugene Han, Hye Sun Park, Obin Kwon, Eun Yeong Choe, Hye Jin Wang, Yong-ho Lee, Sang-Hak Lee, Chul Hoon Kim, Lee-Kyung Kim, Soo Heon Kwak, Kyong Soo Park, Chul Sik Kim, Eun Seok Kang
Medicine.2016; 95(44): e5155.     CrossRef